Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 1; referees: 2 approved]
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). This review includes new information...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000 Research Ltd
2016-05-01
|
| Serie: | F1000Research |
| Soggetti: | |
| Accesso online: | http://f1000research.com/articles/5-918/v1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|